In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
János MartonABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH, Heinrich-Glaeser-Strasse 10-14, D-01454 Radeberg, Germany.ORCID 0000-0001-9411-7899 Dávid GombosInstitute of Biochemistry, HUN-REN Biological Research Center, Temesvári krt. 62, H-6726 Szeged, Hungary.ORCID 0009-0001-9435-6002 Paul CummingSchool of Psychology and Counselling, Queensland University of Technology, Brisbane, QLD 4059, Australia.ORCID 0000-0002-0257-9621 Tamás FehérInstitute of Biochemistry, HUN-REN Biological Research Center, Temesvári krt. 62, H-6726 Szeged, Hungary.
Alexander MilentyevABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH, Heinrich-Glaeser-Strasse 10-14, D-01454 Radeberg, Germany.ORCID 0000-0003-1896-3799 Beate BauerABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH, Heinrich-Glaeser-Strasse 10-14, D-01454 Radeberg, Germany.
Frode WillochInstitute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, N-0317 Oslo, Norway.ORCID 0000-0002-3328-106X Bent Wilhelm SchoultzDepartment of Physics, University of Oslo, P.O. Box 1048, Blindern, N-0316 Oslo, Norway.ORCID 0009-0004-5401-7067 Sándor BenyheInstitute of Biochemistry, HUN-REN Biological Research Center, Temesvári krt. 62, H-6726 Szeged, Hungary.ORCID 0000-0002-2235-5334 Ferenc ÖtvösInstitute of Biochemistry, HUN-REN Biological Research Center, Temesvári krt. 62, H-6726 Szeged, Hungary.ORCID 0000-0001-7630-5466 Funding
National Biotechnology Laboratory Grant of Hungary NRDIO Grant No. 2022-2.1.1-NL-2022-00008
6 · The paper itselfAbstract
We present the first preparation of novel 6-
Indexed as
RadiopharmaceuticalsComputer SimulationFluorine RadioisotopesHumansLigandsMolecular Docking SimulationPositron-Emission TomographyReceptors, OpioidFluorine RadioisotopesLigandsRadiopharmaceuticalsReceptors, Opioid6,14-ethenomorphinans6-O-fluoroalkyl-6-O-desmethyl-diprenorphinediprenorphinein silico dockingopioid receptorspositron emission tomography
Identifiers
PMID41096695
PMCPMC12524955
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390